The global clinical nutrition market reached USD 55.8 billion in 2024 and is forecast to surge to USD 104.6 billion by 2033, growing at a CAGR of 7.2%. This growth is fuelled by rising chronic disease prevalence, technological breakthroughs in personalized and medical nutrition, ageing demographics, and changing dietary habits - all of which are promoting awareness and demand for clinical nutrition solutions.

STUDY ASSUMPTION YEARS

• BASE YEAR: 2024

• HISTORICAL YEAR: 2019–2024

• FORECAST YEAR: 2025–2033

CLINICAL NUTRITION MARKET KEY TAKEAWAYS

• Asia‑Pacific holds the largest regional market share, supported by rising chronic disease burden and expanding healthcare access.

• Infant nutrition remains the top product segment, fulfilling early developmental dietary needs.

• Oral administration leads the route segment due to convenience, safety, and broad acceptance.

• Application-wise, cancer-related nutrition support and malnutrition interventions are fuelling adoption.

• Pediatric end-users dominate demand, driven by high child populations and targeted nutritional formulations.

• Market growth: from USD 55.8 B in 2024 to USD 104.6 B by 2033, at 7.2% CAGR.

MARKET GROWTH FACTORS

 1. Aging Population and Chronic Disease (Diabetes, Cancer, Osteoporosis) Management

The importance of nutrition in managing chronic diseases is a major factor propelling the clinical nutrition market forward. With the global rise in chronic conditions such as diabetes, cancer, and osteoporosis, coupled with an aging population, there’s a growing need for specialized nutritional products and services designed for these specific health challenges. This demand for therapeutic formulas, supplements, and customized nutritional support aims to enhance patient outcomes and overall quality of life. It’s also encouraging innovation among clinical nutrition manufacturers, who are developing new products and integrated digital services, including personalized dietary plans and telehealth solutions, to cater to these intricate patient needs. As healthcare systems increasingly acknowledge the cost-effectiveness of nutritional therapy in both prevention and management, it boosts investment and demand, ultimately driving the growth of the clinical nutrition market.

2. Personalized and Targeted Nutrition:

Personalized nutrition solutions offer tailored dietary advice by taking into account a wealth of individual information, such as health status, genetics, lifestyle, and gut microbiome. This method specifically targets conditions like diabetes, heart disease, or digestive issues, focusing on needs like managing blood sugar levels or pinpointing trigger foods. Important elements include medical history (like diseases, allergies, and biochemical markers), genomic insights (such as DNA and rare metabolic conditions), as well as lifestyle and phenotypic factors (including body composition, activity levels, preferences, and socioeconomic background), along with gut microbiota analysis. The process involves gathering extensive data, analyzing it, and integrating it to create a clear picture of a person’s unique physiological and behavioral traits, leading to personalized dietary recommendations. These plans are regularly monitored and adjusted based on health outcomes, ensuring that the interventions stay effective and practical, ultimately enhancing adherence, metabolic health, and overall wellness for individuals with chronic conditions.

3. Technological Integration:

Genomics, AI, and digital health platforms are shaking up the world of clinical nutrition by offering personalized dietary advice like never before. Nutrigenomics dives into a person’s genetic makeup to figure out their nutritional needs, metabolic characteristics, and even their risk for diet-related illnesses, paving the way for customized interventions. Meanwhile, AI sifts through complex data - think genetic info, lifestyle habits, dietary choices, and microbiome details - to spot trends, forecast how individuals will react to different foods, and help manage chronic issues such as diabetes. It even streamlines dietary tracking with tools like image recognition for precise nutrient evaluation. Digital health platforms pull together data from wearables, biosensors, blood tests, microbiome studies, and electronic health records to offer real-time monitoring and practical insights. When combined, these technologies give patients tailored recommendations, boost adherence, and improve overall well-being. For instance, platforms like ZOE merge glucose, microbiome, and metabolic data to provide dynamic dietary guidance aimed at achieving optimal metabolic health.

Request for a sample copy of this report: 

https://www.imarcgroup.com/clinical-nutrition-market/requestsample

MARKET SEGMENTATION

Breakup by Product:

• Infant Nutrition: addresses the dietary needs of newborns with formula and supplements

• Parental Nutrition

• Enteral Nutrition

Breakup by Route of Administration:

• Oral

• Enteral

• Parenteral

Breakup by Application:

• Cancer

• Malnutrition

• Metabolic Disorders

• Gastrointestinal Disorders

• Neurological Disorders

• Others

Breakup by End User:

• Pediatric

• Adults

• Geriatric

Breakup by Region:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

REGIONAL INSIGHTS

Asia‑Pacific leads the clinical nutrition market, propelled by rapid urbanization, rising chronic disease incidence, and expanding geriatric populations in India and China. With improving healthcare access and higher disposable incomes, demand for specialized nutrition and preventive therapy continues to grow strongly.

RECENT DEVELOPMENTS & NEWS

Recent innovations include Nestlé Health Science’s 2023 partnership with EraCal Therapeutics to develop new nutraceuticals targeting metabolic diseases, reflecting a shift toward functional, health-focused foods. Danone’s May 2024 acquisition of U.S. tube‑feeding specialist Functional Formularies has bolstered its enteral nutrition portfolio and U.S. presence. Friesland Campina Ingredients released Nutri Whey™ ProHeat, a heat-stable whey protein for medical nutrition, showcasing cutting-edge ingredient innovation.

KEY PLAYERS

Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc, Reckitt Benckiser Group PLC, etc.

Ask Analyst for Customization: 

https://www.imarcgroup.com/request?type=report&id=5995&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:
IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: (+1-201971-6302)